Basepoint Wealth’s Cardinal Health CAH Stock Holding History

Basepoint Wealth’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.1K	Sell	203 -13	-6%	-$2.7K	0.03%	225
2026 Q1	$45.6K	Buy	216 +1	+0.5%	+$215	0.03%	224
2025 Q4	$44.3K	Buy	+215	New	+$40.5K	0.03%	220

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Basepoint Wealth's CAH Position: Q2 2026 in Review

Basepoint Wealth reduced its Cardinal Health (CAH) stake by 6% in Q2 2026, selling an estimated $2.7K and leaving 203 shares worth $48.1K. The position accounts for 0.03% of the portfolio, ranked #225.

Basepoint Wealth first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Basepoint Wealth held 203 shares of Cardinal Health worth $48.1K as of Q2 2026.
Basepoint Wealth sold 13 Cardinal Health shares in Q2 2026, an estimated $2.7K.
Cardinal Health made up 0.03% of Basepoint Wealth's portfolio in Q2 2026, its #225 holding.
Basepoint Wealth first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.